Human tumor blood flow is enhanced by nicotinamide and carbogen breathing

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5261-5264

  Powell, Melanie E B ^a   Hill, Sally A ^b   Saunders, Michele I ^a   Hoskin, Peter J ^a   Chaplin, David J ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; NICOTINAMIDE; PLACEBO;

ADULT; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREATHING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LASER DOPPLER FLOWMETRY; OXYGENATION; PERFUSION; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; CARBON DIOXIDE; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; NEOPLASMS; NIACINAMIDE; OXYGEN; PERFUSION; REGIONAL BLOOD FLOW;

EID: 0030712179     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Overgaard, J., and Horsman, M. R. Modification of hypoxia-induced radioresistance in tumours by the use of oxygen and sensitisers. Semin. Radiat. Oncol., 6: 10-21, 1996.
2. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol., 26: 45-50, 1993.
3. Ishizaka, S., Kimoto, M., and Tsujii, T. Defect in generation of LAK cell activity under oxygen limited conditions. Immunol. Lett., 32: 209-214, 1992.
4. Sampson, L., and Chaplin, D. J. The influence of microenvironment on the cytotoxicity of TNF α in vitro. Int. J. Radiat. Oncol. Biol. Phys., 29: 467-471, 1994.
5. Vaupel, P., Frinak, S., and Bicher, H. I. Heterogenous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res., 41: 2008-2013, 1981.
6. 2 tension measurements. Cancer Res., 51: 3316-3322, 1991.
7. Thomlinson, R. H., and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9: 539-549, 1955.
8. Chaplin, D. J., Olive, P. L., and Durand, R. E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res., 47: 597-601, 1987.
9. 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. Br. J. Cancer, 75: 62-68, 1997.
10. Hoskin, P. J., Saunders, M. I., Phillips, H., Cladd, H., Powell, M. E. B., Goodchild, K., Stratford, M. I., and Rojas, A. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br. J. Cancer, 76: 260-263, 1997.
11. Saunders, M., and Dische, S. Clinical results of hypoxic cell radiosensitisation from hyberbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Br. J. Cancer, 74: 271-278, 1996.
12. Chaplin, D. J., Horsman, M. R., and Trotter, M. J. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J. Natl. Cancer Inst., 82: 672-676, 1990.
13. Rojas, A., Hirst, V. K., Calvert, A., and Johns, H. Carbogen and nicotinamide as radio-sensitisers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 34: 357-365, 1996.
14. Hill, S. A., Pigott, K. H., Saunders, M. I., Powell, M. E. B., Arnold, S., Obeid, A., Ward, G., Leahy, M., Hoskin, P. J., and Chaplin, D. J. Microregional blood flow fluctuations in murine and human tumours assessed using laser Doppler microprobes. Br. J. Cancer, 74: 260-263, 1996.
15. Powell, M. E. B., Hill, S. A., Saunders, M. I., Hoskin, P. J., and Chaplin, D. J. Effect of carbogen breathing on tumour microregional blood flow in humans. Radiother. Oncol., 41: 225-231, 1996.
16. Hoskin, P. J., Stratford, M. R., Saunders, M. I., Hall, D. W., Dennis, M. F., and Rojas, A. Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity. Int. J. Radiat. Oncol. Biol. Phys., 32: 1111-1119, 1995.
17. Stratford, M., and Dennis, M. High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine. J. Chromatogr., 582: 145-151, 1992.
18. Stratford, M., Dennis, M., Hoskin, P., Phillips, H., Hodgkiss, R., and Rojas, A. Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal versus oral administration and the use of saliva for drug monitoring. Br. J. Cancer, 74: 16-21, 1996.
19. Dische, S., Rojas, A., Rugg, T., Hong, A., and Michael, B. D. Carbogen breathing: a system for use in man. Br. J. Radiol., 65: 87-90, 1992.
20. Honess, D. J., and Bleehen, N. M. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined. Br. J. Cancer, 71: 1175-1180, 1995.
21. Dewhirst, M. W., Ong, E. T., Rosner, G. L., Rehmus, S. W., Shan, S., Braun, R. D., Brizel, D. M., and Secomb, T. W. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br. J. Cancer, 74: S241-S246, 1996.
22. 2, microcirculatory function and radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys., in press, 1998.
23. Yoshimoto, S., Ishizaki, Y., Sasaki, T., and Murota, S. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke, 22: 378-383, 1991.
24. Pellat-Deceunynck, C., Wietzerbin, J., and Drapier, J-C. Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochemistry, 297: 53-58, 1994.